The 6 analysts offering 12-month price forecasts for G1 Therapeutics Inc have a median target of 9.50, with a high estimate of 19.00 and a low estimate of 5.00. The median estimate represents a +672.36% increase from the last price of 1.23.
The current consensus among 8 polled investment analysts is to Buy stock in G1 Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.41
Reporting Date Nov 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.